Legal & General Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.7K | Buy |
|
|||||
|
2025
Q1 | $6.83K | Hold |
|
|||||
|
2024
Q4 | $14.3K | Sell |
|
|||||
|
2024
Q3 | $313K | Hold |
|
|||||
|
2024
Q2 | $293K | Buy |
|
|||||
|
2024
Q1 | $91K | Sell |
|
|||||
|
2023
Q4 | $65.9K | Sell |
|
|||||
|
2023
Q3 | $116K | Sell |
|
|||||
|
2023
Q2 | $382K | Sell |
|
|||||
|
2023
Q1 | $1.91M | Buy |
|
|||||
|
2022
Q4 | $1.21M | Buy |
|
|||||
|
2022
Q3 | $2.41M | Sell |
|
|||||
|
2022
Q2 | $3.02M | Buy |
|
|||||
|
2022
Q1 | $4.12M | Buy |
|
|||||
|
2021
Q4 | $5.93M | Buy |
|
|||||
|
2021
Q3 | $5.6M | Buy |
|
|||||
|
2021
Q2 | $4.94M | Buy |
|
|||||
|
2021
Q1 | $4.25M | Sell |
|
|||||
|
2020
Q4 | $4.77M | Buy |
|
|||||
|
2020
Q3 | $1.89M | Buy |
|
|||||
|
2020
Q2 | $778K | Buy |
|
|||||
|
2020
Q1 | $491K | Sell |
|
|||||
|
2019
Q4 | $606K | Buy |
|
|||||
|
2019
Q3 | $423K | Buy |
|
|||||
|
2019
Q2 | $218K | Sell |
|
|||||
|
2019
Q1 | $206K | Buy |
|
|||||
|
2018
Q4 | $146K | Buy |
|
|||||
|
2018
Q3 | $125K | Hold |
|
|||||
|
2018
Q2 | $87K | Sell |
|
|||||
|
2018
Q1 | $83K | Buy |
|
|||||
|
2017
Q4 | $48K | Buy |
|
|||||
|
2017
Q3 | $22K | Hold |
|
|||||
|
2017
Q2 | $18K | Buy |
|